Vitcheva V, Sharif MA, Tsakovska I, et al. “Description of the MoA/AOP linked with PPARgamma receptor dysregulation leading to liver fibrosis.” Toxicology Letters. 2014;229:S49.
Cherkasov A, Muratov EN, Fourches D, et al. “QSAR Modeling: Where Have You Been? Where Are You Going To?” Journal of Medicinal Chemistry. 2014;57(12):4977-5010.
The presentations shown at the SOT Annual Meeting and ToxExpo 2014 are now available on our website.
Liu M, Bienfait B, Sacher O, et al. “Combining Chemoinformatics with Bioinformatics: In Silico Prediction of Bacterial Flavor-Forming Pathways by a Chemical Systems Biology Approach “Reverse Pathway Engineering”.” PLoS ONE. 2014;9(1):e84769.
Richarz A-N, Enoch S, Hewitt M, et al. “In silico workflows for toxicity prediction implemented into KNIME.” Toxicology Letters. 2013;221:S81.
Yang C, Ambrosio M, Arvidson K, et al. “Development of new COSMOS oRepeatDose and non-cancer Threshold of Toxicological Concern (TTC) databases to support alternative testing methods for cosmetics related chemicals.” Toxicology Letters. 2013;221:S80.
Williams FM, Ambrosio M, Barrett G, et al. “Threshold of toxicological concern (TTC) task force: a strategy to support application of TTC to dermally applied cosmetic ingredients.” Toxicology Letters. 2013;221:S35.
Bienfait B, Ertl P. “JSME: a free molecule editor in JavaScript.” Journal of Cheminformatics. 2013;5(1):24.
Briggs K, Cases M, Heard DJ, et al. “Inroads to Predict in Vivo Toxicology-An Introduction to the eTOX Project.” Int. J. Mol. Sci.. 2012;13(3).
Anzali S, Berthold MR, Fioravanzo E, et al. “Development of computational models for the risk assessment of cosmetic ingredients.” IFSCC Magazine. 2012;15:249-255.
Altamira LLC
470 W Broad St, Unit #5007
Columbus, Ohio
43215, USA
Tel: +1 614 327 5196
Molecular Networks GmbH –
Computerchemie
Neumeyerstraße 22-34
90411 Nürnberg, Germany
Tel: +49 911 597 424 00
Fax: +49 911 597 424 09
© 2025 Molecular Networks GmbH, Germany and Altamira, LLC, USA. All rights reserved.
We use cookies on our website to enhance the user experience and to analyze traffic. We may share your site usage data with our analytics software providers. By clicking “Accept & Close,” you are consenting to the terms described on our Disclaimer page.